NEW YORKand PETACH TIKVAH, Israel, June 25, 2018/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell
More From BioPortfolio on "BrainStorm to Host Tomorrow a Conference Call to Announce Its Right To Try Policy"